{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:21Z","timestamp":1707524661979},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,24]]},"DOI":"10.7759\/cureus.29543","type":"journal-article","created":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T02:53:46Z","timestamp":1664074426000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictors of Postoperative ICU Admission in Patients With COVID-19-Associated Mucormycosis"],"prefix":"10.7759","author":[{"given":"Vibhor","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geetanjali T","family":"Chilkoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medha","family":"Mohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh K","family":"Meena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta S","year":"2020","unstructured":"Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020, 12:e10726. 10.7759\/cureus.10726","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson TM","year":"2020","unstructured":"Rawson TM, Moore LS, Zhu N, et al.. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020, 71:2459-68. 10.1093\/cid\/ciaa530","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: we should be prepared","volume":"30","author":"Gangneux JP","year":"2020","unstructured":"Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med. 2020, 30:100971. 10.1016\/j.mycmed.2020.100971","journal-title":"J Mycol Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3201\/eid2611.203504","article-title":"Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020","volume":"26","author":"Chowdhary A","year":"2020","unstructured":"Chowdhary A, Tarai B, Singh A, Sharma A. Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020. Emerg Infect Dis. 2020, 26:2694-6. 10.3201\/eid2611.203504","journal-title":"Emerg Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13135","article-title":"COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: an observational study from Pakistan","volume":"63","author":"Nasir N","year":"2020","unstructured":"Nasir N, Farooqi J, Mahmood SF, Jabeen K. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: an observational study from Pakistan. Mycoses. 2020, 63:766-70. 10.1111\/myc.13135","journal-title":"Mycoses"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.09.032","article-title":"Mucormycosis with orbital compartment syndrome in a patient with COVID-19","volume":"42","author":"Werthman-Ehrenreich A","year":"2021","unstructured":"Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. 2021, 42:264.e5-8. 10.1016\/j.ajem.2020.09.032","journal-title":"Am J Emerg Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada A","year":"2020","unstructured":"Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi (Basel). 2020, 6:265. 10.3390\/jof6040265","journal-title":"J Fungi (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash H","year":"2021","unstructured":"Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021, 9:523. 10.3390\/microorganisms9030523","journal-title":"Microorganisms"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh AK","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021, 15:102146. 10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2019.07.001","article-title":"Anesthetic management of rhinoorbitocerebral mucormycosis; focus on challenges","volume":"29","author":"Karaaslan E","year":"2019","unstructured":"Karaaslan E. Anesthetic management of rhinoorbitocerebral mucormycosis; focus on challenges. J Mycol Med. 2019, 29:219-22. 10.1016\/j.mycmed.2019.07.001","journal-title":"J Mycol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - collaborative OPAI-IJO study on mucormycosis in COVID-19 (COSMIC), report 1","volume":"69","author":"Sen M","year":"2021","unstructured":"Sen M, Honavar SG, Bansal R, et al.. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - collaborative OPAI-IJO study on mucormycosis in COVID-19 (COSMIC), report 1. Indian J Ophthalmol. 2021, 69:1670-92. 10.4103\/ijo.IJO_1565_21","journal-title":"Indian J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel A","year":"2021","unstructured":"Patel A, Agarwal R, Rudramurthy SM, et al.. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis. 2021, 27:2349-59. 10.3201\/eid2709.210934","journal-title":"Emerg Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? a retrospective, multi-centric analysis","volume":"20","author":"Moorthy A","year":"2021","unstructured":"Moorthy A, Gaikwad R, Krishna S, et al.. SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? a retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021, 20:418-25. 10.1007\/s12663-021-01532-1","journal-title":"J Maxillofac Oral Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis","volume":"7","author":"John TM","year":"2021","unstructured":"John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021, 7:298. 10.3390\/jof7040298","journal-title":"J Fungi (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_310_21","article-title":"Rise of the phoenix: mucormycosis in COVID-19 times","volume":"69","author":"Ravani SA","year":"2021","unstructured":"Ravani SA, Agrawal GA, Leuva PA, Modi PH, Amin KD. Rise of the phoenix: mucormycosis in COVID-19 times. Indian J Ophthalmol. 2021, 69:1563-8. 10.4103\/ijo.IJO_310_21","journal-title":"Indian J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum","volume":"135","author":"Sharma S","year":"2021","unstructured":"Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol. 2021, 135:442-7. 10.1017\/S0022215121000992","journal-title":"J Laryngol Otol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13334","article-title":"Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicentre study from Iran","volume":"64","author":"Pakdel F","year":"2021","unstructured":"Pakdel F, Ahmadikia K, Salehi M, et al.. Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicentre study from Iran. Mycoses. 2021, 64:1238-52. 10.1111\/myc.13334","journal-title":"Mycoses"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13078","article-title":"Diabetic versus non-diabetic rhino-orbito-cerebral mucormycosis","volume":"63","author":"Abdolalizadeh P","year":"2020","unstructured":"Abdolalizadeh P, Kashkouli MB, Khademi B, Karimi N, Hamami P, Es'haghi A. Diabetic versus non-diabetic rhino-orbito-cerebral mucormycosis. Mycoses. 2020, 63:573-8. 10.1111\/myc.13078","journal-title":"Mycoses"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mmcr.2020.05.008","article-title":"A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well-controlled diabetic patient","volume":"29","author":"Hoang K","year":"2020","unstructured":"Hoang K, Abdo T, Reinersman JM, Lu R, Higuita NI. A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well-controlled diabetic patient. Med Mycol Case Rep. 2020, 29:22-4. 10.1016\/j.mmcr.2020.05.008","journal-title":"Med Mycol Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1086\/516349","article-title":"Rhinocerebral mucormycosis treated with amphotericin B colloidal dispersion in three patients","volume":"26","author":"Moses AE","year":"1998","unstructured":"Moses AE, Rahav G, Barenholz Y, et al.. Rhinocerebral mucormycosis treated with amphotericin B colloidal dispersion in three patients. Clin Infect Dis. 1998, 26:1430-3. 10.1086\/516349","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2000.12.6.463","article-title":"Amphotericin B-induced nephrotoxicity: a review","volume":"12","author":"Fanos V","year":"2000","unstructured":"Fanos V, Cataldi L. Amphotericin B-induced nephrotoxicity: a review. J Chemother. 2000, 12:463-70. 10.1179\/joc.2000.12.6.463","journal-title":"J Chemother"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: side effects and toxicity","volume":"26","author":"Laniado-Labor\u00edn R","year":"2009","unstructured":"Laniado-Labor\u00edn R, Cabrales-Vargas MN. Amphotericin B: side effects and toxicity. Rev Iberoam Micol. 2009, 26:223-7. 10.1016\/j.riam.2009.06.003","journal-title":"Rev Iberoam Micol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2013.45.3.292","article-title":"Risk factors for mortality in patients with invasive mucormycosis","volume":"45","author":"Hong HL","year":"2013","unstructured":"Hong HL, Lee YM, Kim T, et al.. Risk factors for mortality in patients with invasive mucormycosis. Infect Chemother. 2013, 45:292-8. 10.3947\/ic.2013.45.3.292","journal-title":"Infect Chemother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111643","article-title":"Mucormycosis: an opportunistic pathogen during COVID-19","volume":"201","author":"Mahalaxmi I","year":"2021","unstructured":"Mahalaxmi I, Jayaramayya K, Venkatesan D, et al.. Mucormycosis: an opportunistic pathogen during COVID-19. Environ Res. 2021, 201:111643. 10.1016\/j.envres.2021.111643","journal-title":"Environ Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83587-1","article-title":"A single-centre, retrospective study of the incidence of invasive fungal infections during 85\u00a0years of autopsy service in Brazil","volume":"11","author":"Dantas KC","year":"2021","unstructured":"Dantas KC, Mauad T, de Andr\u00e9 CD, Bierrenbach AL, Saldiva PH. A single-centre, retrospective study of the incidence of invasive fungal infections during 85\u00a0years of autopsy service in Brazil. Sci Rep. 2021, 11:3943. 10.1038\/s41598-021-83587-1","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S254478","article-title":"An overview of the management of the most important invasive fungal infections in patients with blood malignancies","volume":"13","author":"Shariati A","year":"2020","unstructured":"Shariati A, Moradabadi A, Chegini Z, Khoshbayan A, Didehdar M. An overview of the management of the most important invasive fungal infections in patients with blood malignancies. Infect Drug Resist. 2020, 13:2329-54. 10.2147\/IDR.S254478","journal-title":"Infect Drug Resist"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114974-predictors-of-postoperative-icu-admission-in-patients-with-covid-19-associated-mucormycosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:56Z","timestamp":1707508076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114974-predictors-of-postoperative-icu-admission-in-patients-with-covid-19-associated-mucormycosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,24]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.29543","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,24]]}}}